Synergy Pharma reports 3Q loss

NEW YORK (AP) _ Synergy Pharmaceuticals Inc. (SGYP) on Thursday reported a loss of $48.9 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 22 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.

The biopharmaceutical company posted revenue of $5 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $5.8 million.

In the final minutes of trading on Thursday, the company's shares hit $2.97. A year ago, they were trading at $5.15.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGYP at https://www.zacks.com/ap/SGYP